Skip to main content
Erschienen in:

13.10.2022 | Original Article

PET morphology helps distinguish solitary and solid pulmonary tuberculosis from non-small cell lung cancer

verfasst von: Qiang Li, Yuan Li, Hui Yuan, Fujun Yang, Yan Huang, Xiao Song, Lei Jiang

Erschienen in: Japanese Journal of Radiology | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective

Solitary and solid pulmonary tuberculosis (PTB) and non-small cell lung cancer (NSCLC) can present overlapping imaging features, causing diagnostic dilemmas. Hence, this study aimed to identify positron emission tomography (PET) morphological features derived from fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) images for a better differential diagnosis.

Methods

Clinical records and 18F-FDG PET/CT images of 175 patients confirmed with PTB and 311 patients with NSCLC were retrospectively reviewed. Parameters including patient demographics, PET-derived morphological features and metabolic parameters, and CT-derived morphological features were investigated. Logistic regression analysis was performed to assess the independent predictive factors associated with PTB.

Results

PTB presented with more heterogeneous glucometabolism than NSCLC in PET imaging (50% vs 17%, P < 0.05), especially in lesions with a maximum diameter < 30 mm (39% vs. 5%, P < 0.05). NSCLC usually showed centric hypometabolism, whereas PTB more frequently presented with an eccentric metabolic pattern, mainly including piebald, half-side, lesser curvature, and greater curvature shapes. Multivariate logistic regression identified that glucometabolic heterogeneity, eccentric hypometabolism, smaller lesion size, calcification, satellite lesions, and higher CT value of the hypometabolic area were independently diagnostic factors for PTB.

Conclusions

Morphological features derived from 18F-FDG PET images helped distinguish solitary and solid PTB from NSCLC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Weber WA, Czernin J, Anderson CJ, et al. The future of nuclear medicine, molecular imaging, and theranostics. J Nucl Med. 2020;61:263s–72s.CrossRefPubMed Weber WA, Czernin J, Anderson CJ, et al. The future of nuclear medicine, molecular imaging, and theranostics. J Nucl Med. 2020;61:263s–72s.CrossRefPubMed
2.
3.
Zurück zum Zitat Shetty N, Noronha V, Joshi A, et al. Diagnostic and treatment dilemma of dual pathology of lung cancer and disseminated tuberculosis. J Clin Oncol. 2014;32:e7-9.CrossRefPubMed Shetty N, Noronha V, Joshi A, et al. Diagnostic and treatment dilemma of dual pathology of lung cancer and disseminated tuberculosis. J Clin Oncol. 2014;32:e7-9.CrossRefPubMed
4.
5.
Zurück zum Zitat Du D, Gu J, Chen X, et al. Integration of PET/CT radiomics and semantic features for differentiation between active pulmonary tuberculosis and lung cancer. Mol Imaging Biol. 2021;23:287–98.CrossRefPubMed Du D, Gu J, Chen X, et al. Integration of PET/CT radiomics and semantic features for differentiation between active pulmonary tuberculosis and lung cancer. Mol Imaging Biol. 2021;23:287–98.CrossRefPubMed
6.
Zurück zum Zitat Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972–80.PubMed Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972–80.PubMed
7.
Zurück zum Zitat Mochizuki T, Tsukamoto E, Kuge Y, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med. 2001;42:1551–5.PubMed Mochizuki T, Tsukamoto E, Kuge Y, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med. 2001;42:1551–5.PubMed
8.
Zurück zum Zitat Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47–59.CrossRefPubMed Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47–59.CrossRefPubMed
9.
Zurück zum Zitat Paik JY, Lee KH, Choe YS, Choi Y, Kim BT. Augmented 18F-FDG uptake in activated monocytes occurs during the priming process and involves tyrosine kinases and protein kinase C. J Nucl Med. 2004;45:124–8.PubMed Paik JY, Lee KH, Choe YS, Choi Y, Kim BT. Augmented 18F-FDG uptake in activated monocytes occurs during the priming process and involves tyrosine kinases and protein kinase C. J Nucl Med. 2004;45:124–8.PubMed
10.
Zurück zum Zitat Wong CY, Nunez R, Bohdiewicz P, et al. Patterns of abnormal FDG uptake by various histological types of non-small cell lung cancer at initial staging by PET. Eur J Nucl Med. 2001;28:1702–5.CrossRefPubMed Wong CY, Nunez R, Bohdiewicz P, et al. Patterns of abnormal FDG uptake by various histological types of non-small cell lung cancer at initial staging by PET. Eur J Nucl Med. 2001;28:1702–5.CrossRefPubMed
11.
Zurück zum Zitat Shim SS, Han J. FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation. Ann Nucl Med. 2010;24:357–62.CrossRefPubMed Shim SS, Han J. FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation. Ann Nucl Med. 2010;24:357–62.CrossRefPubMed
12.
Zurück zum Zitat Ashley Cox R, Akhurst T, Bressel M, MacManus M, Ball D. Survival and central photopenia detected by fluorine-18 fluoro-deoxy-glucose positron emission tomography (FDG-PET) in patients with locoregional non-small cell lung cancer treated with radiotherapy. Radiother Oncol. 2017;124:25–30.CrossRefPubMed Ashley Cox R, Akhurst T, Bressel M, MacManus M, Ball D. Survival and central photopenia detected by fluorine-18 fluoro-deoxy-glucose positron emission tomography (FDG-PET) in patients with locoregional non-small cell lung cancer treated with radiotherapy. Radiother Oncol. 2017;124:25–30.CrossRefPubMed
13.
Zurück zum Zitat Kim HK, Han J, Franks TJ, et al. Colloid Adenocarcinoma of the Lung: CT and PET/CT Findings in seven patients. AJR Am J Roentgenol. 2018;211:W84–91.CrossRefPubMed Kim HK, Han J, Franks TJ, et al. Colloid Adenocarcinoma of the Lung: CT and PET/CT Findings in seven patients. AJR Am J Roentgenol. 2018;211:W84–91.CrossRefPubMed
14.
Zurück zum Zitat Sathekge MM, Maes A, Pottel H, Stoltz A, van de Wiele C. Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area. S Afr Med J. 2010;100:598–601.CrossRefPubMed Sathekge MM, Maes A, Pottel H, Stoltz A, van de Wiele C. Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area. S Afr Med J. 2010;100:598–601.CrossRefPubMed
15.
Zurück zum Zitat Khalaf M, Abdel-Nabi H, Baker J, Shao Y, Lamonica D, Gona J. Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules. J Hematol Oncol. 2008;1:13.CrossRefPubMedPubMedCentral Khalaf M, Abdel-Nabi H, Baker J, Shao Y, Lamonica D, Gona J. Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules. J Hematol Oncol. 2008;1:13.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat du Toit R, Shaw JA, Irusen EM, von Groote-Bidlingmaier F, Warwick JM, Koegelenberg CF. The diagnostic accuracy of integrated positron emission tomography/computed tomography in the evaluation of pulmonary mass lesions in a tuberculosis-endemic area. S Afr Med J. 2015;105:1049–52.CrossRefPubMed du Toit R, Shaw JA, Irusen EM, von Groote-Bidlingmaier F, Warwick JM, Koegelenberg CF. The diagnostic accuracy of integrated positron emission tomography/computed tomography in the evaluation of pulmonary mass lesions in a tuberculosis-endemic area. S Afr Med J. 2015;105:1049–52.CrossRefPubMed
17.
Zurück zum Zitat Li Y, Su M, Li F, Kuang A, Tian R. The value of 18F-FDG-PET/CT in the differential diagnosis of solitary pulmonary nodules in areas with a high incidence of tuberculosis. Ann Nucl Med. 2011;25:804–11.CrossRefPubMed Li Y, Su M, Li F, Kuang A, Tian R. The value of 18F-FDG-PET/CT in the differential diagnosis of solitary pulmonary nodules in areas with a high incidence of tuberculosis. Ann Nucl Med. 2011;25:804–11.CrossRefPubMed
18.
Zurück zum Zitat Niyonkuru A, Chen X, Bakari KH, et al. Evaluation of the diagnostic efficacy of (18) F-Fluorine-2-Deoxy-d-Glucose PET/CT for lung cancer and pulmonary tuberculosis in a Tuberculosis-endemic Country. Cancer Med. 2020;9:931–42.CrossRefPubMed Niyonkuru A, Chen X, Bakari KH, et al. Evaluation of the diagnostic efficacy of (18) F-Fluorine-2-Deoxy-d-Glucose PET/CT for lung cancer and pulmonary tuberculosis in a Tuberculosis-endemic Country. Cancer Med. 2020;9:931–42.CrossRefPubMed
19.
Zurück zum Zitat Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol. 2012;12:352–66.CrossRefPubMed Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol. 2012;12:352–66.CrossRefPubMed
21.
Zurück zum Zitat Ekman S, Frodin JE, Harmenberg J, et al. Clinical Phase I study with an Insulin-like Growth Factor-1 receptor inhibitor: experiences in patients with squamous non-small cell lung carcinoma. Acta Oncol. 2011;50:441–7.CrossRefPubMed Ekman S, Frodin JE, Harmenberg J, et al. Clinical Phase I study with an Insulin-like Growth Factor-1 receptor inhibitor: experiences in patients with squamous non-small cell lung carcinoma. Acta Oncol. 2011;50:441–7.CrossRefPubMed
23.
Zurück zum Zitat Fletcher JW, Kymes SM, Gould M, et al. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. J Nucl Med. 2008;49:179–85.CrossRefPubMed Fletcher JW, Kymes SM, Gould M, et al. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. J Nucl Med. 2008;49:179–85.CrossRefPubMed
24.
Zurück zum Zitat Cheng G, Huang H. Prognostic value of (18)F-Fluorodeoxyglucose PET/computed tomography in non-small-cell lung cancer. PET Clin. 2018;13:59–72.CrossRefPubMed Cheng G, Huang H. Prognostic value of (18)F-Fluorodeoxyglucose PET/computed tomography in non-small-cell lung cancer. PET Clin. 2018;13:59–72.CrossRefPubMed
Metadaten
Titel
PET morphology helps distinguish solitary and solid pulmonary tuberculosis from non-small cell lung cancer
verfasst von
Qiang Li
Yuan Li
Hui Yuan
Fujun Yang
Yan Huang
Xiao Song
Lei Jiang
Publikationsdatum
13.10.2022
Verlag
Springer Nature Singapore
Erschienen in
Japanese Journal of Radiology / Ausgabe 3/2023
Print ISSN: 1867-1071
Elektronische ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-022-01351-5

Neu im Fachgebiet Radiologie

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Stören weiße Wände und viel Licht die Bildqualitätskontrolle?

Wenn es darum geht, die technische Qualität eines Mammogramms zu beurteilen, könnten graue Wandfarbe und reduzierte Beleuchtung im Bildgebungsraum von Vorteil sein. Darauf deuten zumindest Ergebnisse einer kleinen Studie hin. 

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.